These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 15541261

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT.
    Am J Cardiol; 2006 Jul 01; 98(1):102-6. PubMed ID: 16784930
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of the clinical, hemodynamic and neurohormonal response to levosimendan administration in decompensated heart failure patients. One-month follow-up.
    Sargento L, Brito D, Matias JS, Madeira H.
    Rev Port Cardiol; 2007 Jul 01; 26(7-8):717-26. PubMed ID: 17939581
    [Abstract] [Full Text] [Related]

  • 7. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG, Nikitin N, McGowan J.
    Expert Rev Cardiovasc Ther; 2004 Jan 01; 2(1):9-19. PubMed ID: 15038409
    [Abstract] [Full Text] [Related]

  • 8. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H, Turk U, Ozdogan O, Akyuz S, Kirilmaz B, Alioglu E, Gunduz R, Bozkaya YT, Turkoglu C, Payzin S.
    Cardiovasc Ther; 2008 Jan 01; 26(3):182-8. PubMed ID: 18786088
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Repeated infusions of levosimendan: well tolerated and improves functional capacity in decompensated heart failure - a single-centre experience.
    Parle NM, Thomas MD, Dembo L, Best M, Driscoll GO.
    Heart Lung Circ; 2008 Jun 01; 17(3):206-10. PubMed ID: 18242130
    [Abstract] [Full Text] [Related]

  • 12. Levosimendan compared with dobutamine in low output patients.
    Nieminen MS.
    Minerva Anestesiol; 2003 Apr 01; 69(4):258-63. PubMed ID: 12766717
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study].
    Paksoy F, Ulaş T, Tursun I, Dal MS, Oztekin E, Borlu F.
    Anadolu Kardiyol Derg; 2012 Feb 01; 12(1):16-22. PubMed ID: 22214738
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.
    Nieminen MS, Akkila J, Hasenfuss G, Kleber FX, Lehtonen LA, Mitrovic V, Nyquist O, Remme WJ.
    J Am Coll Cardiol; 2000 Nov 15; 36(6):1903-12. PubMed ID: 11092663
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic-pharmacodynamic interrelationships of intravenous and oral levosimendan in patients with severe congestive heart failure.
    Põder P, Eha J, Sundberg S, Antila S, Heinpalu M, Loogna I, Planken U, Rantanen S, Lehtonen L.
    Int J Clin Pharmacol Ther; 2003 Aug 15; 41(8):365-73. PubMed ID: 12940594
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.